These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33911167)

  • 1. Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease.
    Kim MN; Han K; Yoo J; Ha Y; Chon YE; Lee JH; Simon TG; Chan AT; Hwang SG
    Sci Rep; 2021 Apr; 11(1):9154. PubMed ID: 33911167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body Weight Variability and the Risk of Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes: A Nationwide Cohort Study.
    Nam GE; Kim W; Han K; Lee CW; Kwon Y; Han B; Park S; Park JH; Kim YH; Kim DH; Kim SM; Choi YS; Cho KH; Park YG
    Diabetes Care; 2020 Sep; 43(9):2234-2241. PubMed ID: 32641375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variabilities in Weight and Waist Circumference and Risk of Myocardial Infarction, Stroke, and Mortality: A Nationwide Cohort Study.
    Kim DH; Nam GE; Han K; Kim YH; Park KY; Hwang HS; Han B; Cho SJ; Jung SJ; Yoon YJ; Roh YK; Cho KH; Park YG
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):933-942. PubMed ID: 33397045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
    Hwang YC; Ahn HY; Park SW; Park CY
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.
    Lee CH; Han KD; Kim DH; Kwak MS
    Front Endocrinol (Lausanne); 2021; 12():638615. PubMed ID: 33776934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study.
    Lee DY; Han K; Park S; Yu JH; Seo JA; Kim NH; Yoo HJ; Kim SG; Choi KM; Baik SH; Park YG; Kim NH
    Cardiovasc Diabetol; 2020 Sep; 19(1):144. PubMed ID: 32962711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study.
    Kim JH; Moon JS; Byun SJ; Lee JH; Kang DR; Sung KC; Kim JY; Huh JH
    Cardiovasc Diabetol; 2020 May; 19(1):51. PubMed ID: 32359355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
    Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
    Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
    Kim MK; Han K; Park YM; Kwon HS; Kang G; Yoon KH; Lee SH
    Circulation; 2018 Dec; 138(23):2627-2637. PubMed ID: 30571256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
    Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Avillach P; Egger P; Dhalwani NN; Kendrick S; Celis-Morales C; Waterworth DM; Alazawi W; Sattar N
    BMJ; 2019 Oct; 367():l5367. PubMed ID: 31594780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases.
    Chang Y; Cho J; Cho YK; Cho A; Hong YS; Zhao D; Ahn J; Sohn CI; Shin H; Guallar E; Ryu S
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):205-215.e7. PubMed ID: 31085337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease: A Matched Case-Control Study.
    Liu HH; Cao YX; Sun D; Jin JL; Guo YL; Wu NQ; Zhu CG; Gao Y; Dong QT; Zhao X; Li S; Zhang Y; Liu G; Li JJ
    Clin Transl Gastroenterol; 2019 Feb; 10(2):e00011. PubMed ID: 30829918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.
    Simon TG; Roelstraete B; Khalili H; Hagström H; Ludvigsson JF
    Gut; 2021 Jul; 70(7):1375-1382. PubMed ID: 33037056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
    Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
    Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk.
    Delgado GE; Kleber ME; Moissl AP; Yazdani B; Kusnik A; Ebert MP; März W; Krämer BK; Lammert A; Teufel A
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G252-G261. PubMed ID: 34132110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Kim MK; Han K; Kim HS; Park YM; Kwon HS; Yoon KH; Lee SH
    Eur Heart J; 2017 Dec; 38(48):3560-3566. PubMed ID: 29069458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium intake in relation to all-cause and cardiovascular mortality in individuals with nonalcoholic fatty liver disease: A nationwide study in nutrition.
    Dong X; Deng Y; Chen G
    PLoS One; 2024; 19(5):e0303140. PubMed ID: 38768120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke.
    Chung GE; Cho EJ; Yoo JJ; Chang Y; Cho Y; Park SH; Han K; Jeong SM; Yoon KW; Shin DW; Yu SJ; Kim YJ; Yoon JH
    Diabetes Obes Metab; 2022 Mar; 24(3):465-472. PubMed ID: 34726318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.